Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Illumina Inc (NASDAQ: ILMN) closed at $135.32 down -0.64% from its previous closing price of $136.19. In other words, the price has decreased by -$0.64 from its previous closing price. On the day, 0.6 million shares were traded. ILMN stock price reached its highest trading level at $136.535 during the session, while it also had its lowest trading level at $132.93.
Ratios:
For a deeper understanding of Illumina Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.18 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.68. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 1.08 whereas as Long-Term Debt/Eq ratio is at 0.63.
On July 11, 2025, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform but kept the price unchanged to $125.
Citigroup reiterated its Neutral rating for the stock on March 04, 2025, while the target price for the stock was revised from $130 to $90.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 12 ’25 when Davies Scott M sold 323 shares for $136.09 per share. The transaction valued at 43,957 led to the insider holds 17,887 shares of the business.
SCOTT DAVIES bought 323 shares of ILMN for $43,957 on Dec 12 ’25. On Dec 08 ’25, another insider, Wedel Christensen Jakob, who serves as the SVP, Strategy/Corp Development of the company, sold 549 shares for $129.27 each. As a result, the insider received 70,969 and left with 10,952 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ILMN now has a Market Capitalization of 20798685184 and an Enterprise Value of 21974896640. As of this moment, Illumina’s Price-to-Earnings (P/E) ratio for their current fiscal year is 30.32, and their Forward P/E ratio for the next fiscal year is 26.96. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.40. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.83 while its Price-to-Book (P/B) ratio in mrq is 8.70. Its current Enterprise Value per Revenue stands at 5.125 whereas that against EBITDA is 18.83.
Stock Price History:
The Beta on a monthly basis for ILMN is 1.42, which has changed by 0.000369668 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, ILMN has reached a high of $153.06, while it has fallen to a 52-week low of $68.70. The 50-Day Moving Average of the stock is 12.68%, while the 200-Day Moving Average is calculated to be 38.50%.
Shares Statistics:
For the past three months, ILMN has traded an average of 1.83M shares per day and 1807590 over the past ten days. A total of 153.00M shares are outstanding, with a floating share count of 148.51M. Insiders hold about 2.81% of the company’s shares, while institutions hold 104.25% stake in the company. Shares short for ILMN as of 1765756800 were 7411422 with a Short Ratio of 4.06, compared to 1763078400 on 6544061. Therefore, it implies a Short% of Shares Outstanding of 7411422 and a Short% of Float of 7.57.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 16.0 analysts currently analyzing and rating the stock of Illumina Inc (ILMN).The consensus estimate for the next quarter is $1.12, with high estimates of $1.21 and low estimates of $0.98.
Analysts are recommending an EPS of between $4.79 and $4.66 for the fiscal current year, implying an average EPS of $4.71. EPS for the following year is $5.01, with 18.0 analysts recommending between $5.19 and $4.58.
Revenue Estimates
A total of 15 analysts believe the company’s revenue will be $1.1B this quarter.It ranges from a high estimate of $1.12B to a low estimate of $1.09B. As of. The current estimate, Illumina Inc’s year-ago sales were $1.1BFor the next quarter, 15 analysts are estimating revenue of $1.06B. There is a high estimate of $1.09B for the next quarter, whereas the lowest estimate is $1.02B.
A total of 17 analysts have provided revenue estimates for ILMN’s current fiscal year. The highest revenue estimate was $4.31B, while the lowest revenue estimate was $4.27B, resulting in an average revenue estimate of $4.29B. In the same quarter a year ago, actual revenue was $4.37BBased on 17 analysts’ estimates, the company’s revenue will be $4.38B in the next fiscal year. The high estimate is $4.42B and the low estimate is $4.33B.
